Literature DB >> 22267952

Hydrogen exchange mass spectrometry as an analytical tool for the analysis of amyloid fibrillogenesis.

Carsten Scavenius1, Shirin Ghodke, Daniel E Otzen, Jan J Enghild.   

Abstract

In this study, we have used glucagon as a model system for analyzing amyloid fibrillogenesis by hydrogen exchange MALDI mass spectrometry (HXMS). The hydrogen exchange mass spectrometry data correlated well with the traditional method based on Thioflavin T fluorescence and provided quantitative information by measuring the fibrillating molecules directly. The hydrogen exchange mass spectrometry data collected during fibrillogenesis revealed that glucagon fibrillation was a two component system showing an on/off type of interaction where only monomeric and fibrils were present without any substantial amount of intermediate species. This was evident by the extensive deuteration of the monomer and protection of the entire 29 residue glucagon peptide upon fibrillation.. The method complements the traditional procedures and has the potential to provide new information with respect to the nature of transient species, the structure of the growing fibrils and the mechanism of formation.

Entities:  

Year:  2011        PMID: 22267952      PMCID: PMC3261750          DOI: 10.1016/j.ijms.2010.10.001

Source DB:  PubMed          Journal:  Int J Mass Spectrom        ISSN: 1387-3806            Impact factor:   1.986


  29 in total

1.  Quantification of beta-sheet amyloid fibril structures with thioflavin T.

Authors:  H LeVine
Journal:  Methods Enzymol       Date:  1999       Impact factor: 1.600

2.  A thermodynamic analysis of fibrillar polymorphism.

Authors:  Martin D Jeppesen; Kim Hein; Poul Nissen; Peter Westh; Daniel E Otzen
Journal:  Biophys Chem       Date:  2010-04-09       Impact factor: 2.352

3.  The changing face of glucagon fibrillation: structural polymorphism and conformational imprinting.

Authors:  Jesper Søndergaard Pedersen; Dantcho Dikov; James L Flink; Hans Aage Hjuler; Gunna Christiansen; Daniel Erik Otzen
Journal:  J Mol Biol       Date:  2005-11-09       Impact factor: 5.469

4.  Semi-automated data processing of hydrogen exchange mass spectra using HX-Express.

Authors:  David D Weis; John R Engen; Ignatius J Kass
Journal:  J Am Soc Mass Spectrom       Date:  2006-08-22       Impact factor: 3.109

5.  Glucagon amyloid-like fibril morphology is selected via morphology-dependent growth inhibition.

Authors:  Christian Beyschau Andersen; Daniel Otzen; Gunna Christiansen; Christian Rischel
Journal:  Biochemistry       Date:  2007-05-25       Impact factor: 3.162

6.  The common architecture of cross-beta amyloid.

Authors:  Thomas R Jahn; O Sumner Makin; Kyle L Morris; Karen E Marshall; Pei Tian; Pawel Sikorski; Louise C Serpell
Journal:  J Mol Biol       Date:  2009-09-23       Impact factor: 5.469

7.  Hydrogen/deuterium exchange mass spectrometry analysis of protein aggregates.

Authors:  Indu Kheterpal; Kelsey D Cook; Ronald Wetzel
Journal:  Methods Enzymol       Date:  2006       Impact factor: 1.600

8.  Abeta amyloid fibrils possess a core structure highly resistant to hydrogen exchange.

Authors:  I Kheterpal; S Zhou; K D Cook; R Wetzel
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

9.  Thioflavin T hydroxylation at basic pH and its effect on amyloid fibril detection.

Authors:  Vito Foderà; Minna Groenning; Valeria Vetri; Fabio Librizzi; Salvatore Spagnolo; Claus Cornett; Lars Olsen; Marco van de Weert; Maurizio Leone
Journal:  J Phys Chem B       Date:  2008-11-27       Impact factor: 2.991

10.  Sulfates dramatically stabilize a salt-dependent type of glucagon fibrils.

Authors:  Jesper Søndergaard Pedersen; James M Flink; Dantcho Dikov; Daniel Erik Otzen
Journal:  Biophys J       Date:  2006-03-13       Impact factor: 4.033

View more
  1 in total

1.  Structural transitions and interactions in the early stages of human glucagon amyloid fibrillation.

Authors:  Balakrishnan S Moorthy; Hamed Tabatabaei Ghomi; Markus A Lill; Elizabeth M Topp
Journal:  Biophys J       Date:  2015-02-17       Impact factor: 4.033

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.